Human α-ketoglutarate-dependent dioxygenase AlkB homolog 2 (ALKBH2) directly reverses these lesions and was reported to contribute to glioblastoma resistance to TMZ (82). This evidence concerns the gene ALKBH2 and glioblastoma.